E-LIB Suche - Ergebnisse für: Wissner, Allan

1

Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors f..:

Kim, Kyung-Hee ; Maderna, Andreas ; Schnute, Mark E....
Bioorganic & Medicinal Chemistry Letters. 21 (2011) 21 - p. 6258-6263 , 2011

Link: https://doi.org/10.1016/..

2

Synthesis and PKCθ inhibitory activity of a series of 4-ind..:

Dushin, Russell G. ; Nittoli, Thomas ; Ingalls, Charles...
Bioorganic & Medicinal Chemistry Letters. 19 (2009) 9 - p. 2461-2463 , 2009

Link: https://doi.org/10.1016/..

3

Benzo[c][2,7]naphthyridines as inhibitors of PDK-1:

Kim, Kyung-Hee ; Wissner, Allan ; Floyd Jr., Middleton B....
Bioorganic & Medicinal Chemistry Letters. 19 (2009) 17 - p. 5225-5228 , 2009

Link: https://doi.org/10.1016/..

4

Kinase Domain Mutations in Cancer: Implications for Small M..:

Bikker, Jack A. ; Brooijmans, Natasja ; Wissner, Allan.
Journal of Medicinal Chemistry. 52 (2009) 6 - p. 1493-1509 , 2009

Link: https://doi.org/10.1021/..

5

Identification, Characterization and Initial Hit-to-Lead Op..:

Cole, Derek C. ; Asselin, Magda ; Brennan, Agnes...
Journal of Medicinal Chemistry. 51 (2008) 19 - p. 5958-5963 , 2008

Link: https://doi.org/10.1021/..

6

The Development of HKI‐272 and Related Compounds for the Tr..:

Wissner, Allan ; Mansour, Tarek S.
Archiv der Pharmazie. 341 (2008) 8 - p. 465-477 , 2008

Link: https://doi.org/10.1002/..

7

Dual irreversible kinase inhibitors: Quinazoline-based inhi..:

Wissner, Allan ; Fraser, Heidi L. ; Ingalls, Charles L....
Bioorganic & Medicinal Chemistry. 15 (2007) 11 - p. 3635-3648 , 2007

Link: https://doi.org/10.1016/..

8

2-(Quinazolin-4-ylamino)-[1,4]benzoquinones as Covalent-Bin..:

Wissner, Allan ; Floyd, M. Brawner ; Johnson, Bernard D....
Journal of Medicinal Chemistry. 48 (2005) 24 - p. 7560-7581 , 2005

Link: https://doi.org/10.1021/..

9

Irreversible Inhibitors of the EGF Receptor May Circumvent ..:

Kwak, Eunice L. ; Sordella, Raffaella ; Bell, Daphne W....
Proceedings of the National Academy of Sciences of the United States of America. 102 (2005) 21 - p. 7665-7670 , 2005

Link: https://www.jstor.org/st..

10

Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-..:

Tsou, Hwei-Ru ; Overbeek-Klumpers, Elsebe G. ; Hallett, William A....
Journal of Medicinal Chemistry. 48 (2005) 4 - p. 1107-1131 , 2005

Link: https://doi.org/10.1021/..

11

Irreversible inhibitors of the EGF receptor may circumvent ..:

Kwak, Eunice L. ; Sordella, Raffaella ; Bell, Daphne W....
Proceedings of the National Academy of Sciences. 102 (2005) 21 - p. 7665-7670 , 2005

Link: https://doi.org/10.1073/..

12

Syntheses and EGFR kinase inhibitory activity of 6-substitu..:

Wissner, Allan ; Hamann, Philip R. ; Nilakantan, Ramaswamy...
Bioorganic & Medicinal Chemistry Letters. 14 (2004) 6 - p. 1411-1416 , 2004

Link: https://doi.org/10.1016/..

13

Synthesis and evaluation of 4-Anilino-6,7-dialkoxy-3-quinol..:

Berger, Dan ; Dutia, Minu ; Powell, Dennis...
Bioorganic & Medicinal Chemistry Letters. 13 (2003) 18 - p. 3031-3034 , 2003

Link: https://doi.org/10.1016/..

14

4-Anilino-3-cyanobenzo[g]quinolines as Kinase Inhibitors:

Zhang, Nan ; Wu, Biqi ; Wissner, Allan...
Bioorganic & Medicinal Chemistry Letters. 12 (2002) 3 - p. 423-425 , 2002

Link: https://doi.org/10.1016/..

15

Synthesis and Structure−Activity Relationships of 6,7-Disub..:

Wissner, Allan ; Overbeek, Elsebe ; Reich, Marvin F....
Journal of Medicinal Chemistry. 46 (2002) 1 - p. 49-63 , 2002

Link: https://doi.org/10.1021/..